Pfizer Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 478 trades in Pfizer Inc (NYSE: PFE) since 2013, across 84 members, worth an estimated $6.6M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 226 buys against 249 sells, a modestly sell-led skew, with Democratic members responsible for 63% of the trades and Republican members 37%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most PFE transactions among those shown, with 12. Other recent filers include Tommy Tuberville, Alan Armstrong, and Gilbert Cisneros. One notable disclosed move was a purchase by Rohit Khanna on July 7, 2026, up 18.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Pfizer Inc's current Quantellect Tide Score is 55 out of 100 (High Tide), Top 40% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Pfizer Inc (PFE) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Pfizer congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Aug 7, 2026 | Jul 7, 2026 | 31 days | BUY |  $1,001 - $15,000 | +18.70% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | SELL | $1,001 - $15,000 | +9.72% | Spouse | |
 Tommy Tuberville Senate | Jul 16, 2026 | Jun 8, 2026 | 38 days | SELL | $15,001 - $50,000 | +11.51% | Joint | |
Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | SELL | $15,001 - $50,000 | +11.82% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $1,001 - $15,000 | +12.79% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +6.22% | Spouse | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 24, 2026 | 119 days | SELL | $50,001 - $100,000 | +7.72% | Self | |
 Gilbert Cisneros House | Apr 7, 2026 | Mar 13, 2026 | 25 days | SELL | $1,001 - $15,000 | +9.26% | Self | |
Gilbert Cisneros House | Mar 9, 2026 | Feb 10, 2026 | 27 days | BUY | $1,001 - $15,000 | +5.18% | Self | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | SELL | $15,001 - $50,000 | +11.27% | Spouse |
Pfizer (PFE) congressional trading FAQ
Can members of Congress legally trade Pfizer (PFE) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Pfizer (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Pfizer (PFE) trades public?
Yes. Every congressional trade in Pfizer (PFE) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Pfizer (PFE)?
Members of Congress have disclosed 478 trades in Pfizer (PFE) worth $6.6M across 84 members, according to public STOCK Act filings.
Which members of Congress have traded Pfizer (PFE)?
Recent and active filers of Pfizer (PFE) disclosures include Rohit Khanna, Gilbert Cisneros, Tommy Tuberville. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Pfizer (PFE) more?
Across disclosed Pfizer (PFE) trades, 63% were by Democrats and 37% by Republicans, led by Democrats (63%).
What is the most recent congressional Pfizer (PFE) trade?
The most recent disclosed Pfizer (PFE) trade was a purchase by Rohit Khanna, filed Aug 6, 2026.
What is Pfizer (PFE)'s Tide Score?
Pfizer (PFE) has a Quantellect Tide Score of 55 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewPfizer (PFE) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.